Related Experiment Video
Updated: May 12, 2026
12:13
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Epigenomic alterations in localized and advanced prostate cancer
Pei-Chun Lin1, Eugenia G Giannopoulou, Kyung Park
1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Neoplasia (New York, N.Y.)
|April 5, 2013
Summary
Distinguishing indolent prostate cancer (PCa) from aggressive forms is crucial. This study reveals DNA methylation patterns, including allele-specific methylation, linked to PCa progression, offering potential biomarkers for better patient stratification.
Area of Science:
- Epigenetics and Genomics
- Cancer Biology
- Prostate Cancer Research
Background:
- Prostate cancer (PCa) is a leading cause of cancer death in men.
- Differentiating indolent from aggressive PCa is essential for treatment decisions.
- Understanding the molecular basis of PCa progression is critical.
Purpose of the Study:
- To comprehensively characterize the PCa methylome using genome-wide DNA methylation profiling.
- To identify DNA methylation changes associated with PCa disease progression.
- To discover novel prognostic biomarkers for distinguishing PCa subtypes.
Main Methods:
- Employed Enhanced Reduced Representation Bisulfite Sequencing for high-resolution DNA methylation analysis.
- Integrated DNA methylation data with RNA-seq and whole-genome DNA-seq.
- Validated candidate biomarkers in an independent cohort.
Main Results:
- Identified correlation between cytosine guanine dinucleotide island (CGI) hypermethylation and disease severity.
- Discovered widespread allele-specific methylation (ASM) in PCa, linking genetic variations to epigenetic changes.
- Validated a panel of 13 CGIs showing increased DNA methylation with disease progression.
Conclusions:
- DNA methylation patterns, particularly ASM, play a significant role in PCa progression.
- The identified CGI panel shows promise as a biomarker for distinguishing PCa subtypes.
- Further clinical evaluation is warranted to assess the utility of these findings in patient management.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...